Professional Supplier of Nano-Targeted Drug Scientific Research Products

cart
Our Products
  • APIs & Intermediates
  • Biotinylation Reagents
  • Phospholipids
  • Lipid PEGs
  • Functional PEGs
  • Polyester PEGs
  • Polyamino Acids
  • Polymers & Copolymers
  • Gold Nanoparticles
  • Iron Oxide Nanoparticles
  • Silica Particles
  • Quantum Dots
  • Upconverting Nanoparticles
  • Inorganic Nanomaterials
  • Fluorescent Dyes
  • Protein & Enzyme Conjugates
  • Polysaccharides
  • PEG Linkers with Small Molecular
  • Crosslinkers
  • Click Chemistry
  • ADC Linkers
  • MOF Materials
  • Liposomes
  • Hydrogels
  • Microspheres
  • AIE Materials
  • New Release
APIs & Intermediates View More
Biotinylation Reagents View More
Phospholipids View More
Lipid PEGs View More
Functional PEGs View More
Polyester PEGs View More
Polyamino Acids View More
Polymers & Copolymers View More
Gold Nanoparticles View More
Iron Oxide Nanoparticles View More
Silica Particles View More
Quantum Dots View More
Upconverting Nanoparticles View More
Inorganic Nanomaterials View More
Fluorescent Dyes View More
Protein & Enzyme Conjugates View More
Polysaccharides View More
PEG Linkers with Small Molecular View More
Crosslinkers View More
Click Chemistry View More
ADC Linkers View More
MOF Materials View More
Liposomes View More
Hydrogels View More
Microspheres View More
AIE Materials View More
New Release View More
Liposomes

Eganelisib (IPI-549) Liposomes, Formulation WNX5.2, Lyophilized Powder | CAS 1693758-51-8

Catalog: TASK-25-6000024   CAS NO.: 1693758-51-8
Delivery Fill in your shipping address to check the estimated shipping fee of your order

Select Shipping Address

$0.00 delivery Normal Delivery(7Days) Details Cyprum itidem insulam procul a continenti

$0.00 delivery Express Delivery Details Cyprum itidem insulam procul a continenti

  • High Quality Products
  • Fast and Safe Delivery

Description

Eganelisib (IPI-549) Liposomes, Formulation WNX5.2, Lyophilized Powder has potential applications in cancer immunotherapy and inflammatory diseases. Eganelisib (formerly known as IPI-549) is an investigational small molecule that acts as a selective inhibitor of phosphoinositide 3-kinase-γ (PI3K-γ). PI3K-γ is an isoform of the phosphoinositide 3-kinase family that is predominantly expressed in immune cells, including macrophages, neutrophils, and other cells involved in the inflammatory response. It plays a key role in regulating immune cell signaling, particularly in the context of inflammation and immune suppression. Eganelisib liposomes (WNX5.2) have wide-ranging therapeutic potential across a variety of conditions, primarily in cancer immunotherapy and inflammatory diseases. By selectively inhibiting PI3K-γ, WNX5.2 can reprogram the immune system, enhancing anti-tumor responses, reducing chronic inflammation, and potentially improving outcomes in diseases characterized by immune dysregulation.

Specifications

CAS No.1693758-51-8
Lipid CompositionN/A
FormLyophilized Powder
Ship Within1 week
Storage Temp.-20℃
Shipping4-25℃ for up to 3 weeks
Welcome to Taskcm

This email already exists.

Username already exists.

Please confirm the password is the same.

or